Ubs Group Ag Lemaitre Vascular Inc Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Ubs Group Ag holds 26,003 shares of LMAT stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,003

Previous 23,212 12.02%

Holding current value

$2.14 Million

Previous $2.14 Million 2.01%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$78.82 - $104.0 $219,986 - $290,264	2,791 Added 12.02%	26,003 $2.18 Million
Q4 2024 Feb 14, 2025	BUY	$85.64 - $107.97 $1.45 Million - $1.83 Million	16,982 Added 272.58%	23,212 $2.14 Million
Q3 2024 Nov 14, 2024	SELL	$80.3 - $92.89 $205,568 - $237,798	-2,560 Reduced 29.12%	6,230 $578,000
Q2 2024 Aug 13, 2024	SELL	$62.62 - $83.59 $717,312 - $957,523	-11,455 Reduced 56.58%	8,790 $723,000
Q1 2024 May 13, 2024	SELL	$54.0 - $71.06 $40,284 - $53,010	-746 Reduced 3.55%	20,245 $1.34 Million
Q4 2023 Feb 09, 2024	BUY	$45.37 - $58.41 $378,884 - $487,781	8,351 Added 66.07%	20,991 $1.19 Million
Q3 2023 Nov 09, 2023	SELL	$53.45 - $67.01 $438,717 - $550,018	-8,208 Reduced 39.37%	12,640 $688,000
Q2 2023 Aug 11, 2023	BUY	$50.38 - $68.21 $222,780 - $301,624	4,422 Added 26.92%	20,848 $1.4 Million
Q1 2023 May 12, 2023	BUY	$44.73 - $51.68 $344,107 - $397,574	7,693 Added 88.09%	16,426 $845,000
Q4 2022 Feb 08, 2023	BUY	$41.94 - $52.25 $206,764 - $257,592	4,930 Added 129.63%	8,733 $401,000
Q3 2022 Nov 10, 2022	BUY	$45.29 - $55.99 $136,413 - $168,641	3,012 Added 380.78%	3,803 $193,000
Q2 2022 Aug 10, 2022	SELL	$39.05 - $47.85 $151,123 - $185,179	-3,870 Reduced 83.03%	791 $36,000
Q1 2022 May 16, 2022	SELL	$40.48 - $51.5 $82,336 - $104,751	-2,034 Reduced 30.38%	4,661 $217,000
Q4 2021 Feb 14, 2022	BUY	$46.66 - $56.25 $269,274 - $324,618	5,771 Added 624.57%	6,695 $336,000
Q3 2021 Nov 15, 2021	SELL	$53.09 - $60.57 $114,992 - $131,194	-2,166 Reduced 70.1%	924 $49,000
Q2 2021 Aug 13, 2021	SELL	$47.74 - $63.33 $307,445 - $407,845	-6,440 Reduced 67.58%	3,090 $188,000
Q1 2021 May 12, 2021	SELL	$40.19 - $51.5 $178,644 - $228,917	-4,445 Reduced 31.81%	9,530 $465,000
Q4 2020 Feb 11, 2021	BUY	$31.44 - $41.27 $246,521 - $323,598	7,841 Added 127.83%	13,975 $566,000
Q3 2020 Nov 12, 2020	SELL	$25.73 - $33.98 $97,439 - $128,682	-3,787 Reduced 38.17%	6,134 $199,000
Q2 2020 Jul 31, 2020	SELL	$22.88 - $30.71 $51,960 - $69,742	-2,271 Reduced 18.63%	9,921 $262,000
Q1 2020 May 01, 2020	SELL	$21.03 - $38.46 $148,871 - $272,258	-7,079 Reduced 36.73%	12,192 $304,000
Q4 2019 Feb 14, 2020	BUY	$31.27 - $36.21 $172,954 - $200,277	5,531 Added 40.25%	19,271 $693,000
Q3 2019 Nov 14, 2019	BUY	$27.91 - $35.78 $294,422 - $377,443	10,549 Added 330.59%	13,740 $470,000
Q2 2019 Aug 14, 2019	BUY	$25.55 - $30.79 $49,950 - $60,194	1,955 Added 158.17%	3,191 $89,000
Q1 2019 May 14, 2019	SELL	$22.45 - $31.55 $152,345 - $214,098	-6,786 Reduced 84.59%	1,236 $38,000
Q4 2018 Feb 14, 2019	SELL	$22.01 - $37.23 $21,371 - $36,150	-971 Reduced 10.8%	8,022 $189,000
Q3 2018 Nov 14, 2018	BUY	$34.02 - $38.74 $20,752 - $23,631	610 Added 7.28%	8,993 $348,000
Q2 2018 Aug 14, 2018	SELL	$31.45 - $41.02 $204,487 - $266,712	-6,502 Reduced 43.68%	8,383 $280,000
Q1 2018 May 15, 2018	SELL	$30.5 - $37.13 $200,629 - $244,241	-6,578 Reduced 30.65%	14,885 $539,000
Q4 2017 Feb 14, 2018	SELL	$30.9 - $39.01 $65,508 - $82,701	-2,120 Reduced 8.99%	21,463 $683,000
Q3 2017 Nov 14, 2017	BUY	$32.75 - $39.13 $25,807 - $30,834	788 Added 3.46%	23,583 $882,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,906 Added 287.08%	22,795 $712,000
Q1 2017 Nov 14, 2017	BUY	N/A	5,889	5,889 $145,000

Others Institutions Holding LMAT

# of Institutions

296

Shares Held

21.1M

Call Options Held

300

Put Options Held

400

View Full List

About LEMAITRE VASCULAR INC

Ticker LMAT
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 21,962,900
Market Cap $1.81B
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...

More about LMAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account